Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
| ▸ | CDC25C | P30307 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21704887 | 0.83 | CYP1A2 (0.36) | ESR1ESR2L3MBTL1 | |
| SCHEMBL21705051 | 0.81 | GPR84 (0.35) | ESR1ESR2L3MBTL1 | |
| SCHEMBL21705103 | 0.81 | HSP90AA1 (0.33) | — | |
| SCHEMBL21705050 | 0.81 | ADORA2A (0.32) | ESR1ESR2 | |
| SCHEMBL21704891 | 0.80 | MCL1 (0.36) | ESR1ESR2CA1CA2 | |
| SCHEMBL21705104 | 0.80 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL21704888 | 0.80 | SMN1; SMN2 (0.40) | — | |
| SCHEMBL21704893 | 0.79 | CYP1A2 (0.37) | ESR1ESR2 | |
| SCHEMBL21705078 | 0.79 | ABCG2 (0.34) | ESR1ESR2CA1CA2 | |
| SCHEMBL21704892 | 0.79 | CYP1A2 (0.33) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | CANON KABUSHIKI KAISHA (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | CANON KABUSHIKI KAISHA (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | OCIAD1, L1CAM, SPIN4 | ESR1 13/4885ESR2 258/4885TDP1 4439/4885 |
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | OCIAD1, L1CAM, SPIN4 | ESR1 13/4885ESR2 258/4885TDP1 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.